VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EBS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
EBSEmergent BioSolutions Inc.
$8.46$437M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksEBSQuarterly Cash Flow

Emergent BioSolutions Inc. (EBS) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Emergent BioSolutions Inc. (EBS) quarterly cash flow statement — complete operating, investing & financing history

EBS Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Cash from Operations-33.8M77.7M-2.3M106.4M-11.2M-79.9M153.7M47.5M-62.6M32.1M60M-114.4M-184M92.8M-74M-15.6M-37.3M329M16.7M-29.7M
Operating CF Margin %-21.65%52.25%-1%75.51%-5.04%-41.04%52.31%18.65%-20.84%11.61%22.18%-33.86%-111.99%28.1%-30.85%-6.5%-12.13%45.49%5.08%-7.47%
Operating CF Growth %-201.79%197.25%-101.5%124%82.11%-348.91%156.17%141.52%65.98%-65.41%181.08%-633.33%-393.3%-71.79%-543.11%47.47%-831.37%34.23%-84.13%-123.22%
Net Income6.8M-54.6M51.2M-12M68M-31.3M114.8M-283.1M9M-49.5M-263.4M-261.3M-186.2M-88M-84.5M-56.4M-3.7M189.3M-32.7M4.6M
Depreciation & Amortization23.5M23.5M23.4M23.5M25.4M26M26.4M28.5M27.9M29.6M28M32.9M35.7M35.6M32.2M44.5M30.9M29.2M32.7M33.2M
Stock-Based Compensation1.9M5.3M4.8M4.6M1.5M4.3M2.3M5.5M5.9M4M4M8.3M6.8M11.7M11.2M12.3M9.9M10.1M10.4M11.4M
Deferred Taxes-4.5M1.5M-10.2M-13.9M18.6M-400K7.3M-200K-12.2M-5.2M2.7M-1.8M-4.7M-42M22.9M700K1.9M46.3M3.8M-1.5M
Other Non-Cash Items-9.7M20M9.9M8.5M-6M6.8M-62.7M90.9M4.3M6.7M222.9M261M7.3M1.3M12.5M3.9M2.1M-63.4M91.2M100K
Working Capital Changes-51.8M82M-81.4M95.7M-118.7M-85.3M65.6M205.9M-97.5M46.5M65.8M-145.2M-36.1M174.2M-68.3M-20.6M-78.4M117.5M-88.7M-77.5M
Change in Receivables-38.9M51.9M-71.6M118.5M-73.3M-77.1M82.3M20.4M-50M36.9M71.3M-132.4M2.6M38.5M-15.2M4M93.7M66.5M-80M-76.8M
Change in Inventory15.8M14.2M-17.6M-24.7M-2.2M11M-18M-13M-4.5M25.6M-100K5.8M-30.7M60.3M-27.3M-25.4M-50.1M14M21.7M20.2M
Change in Payables-14.4M11.4M-4M-10.4M-5.4M-10.2M-23M2.6M-2.4M-7.1M6.8M-20.1M31M-5M-4.2M7.1M-14.7M-6M-4.5M-12.1M
Cash from Investing-2.4M-3.9M-3.4M17.2M59.5M28.6M112M-4.6M-10.8M-11.4M-18.9M257.7M-15.1M-45.4M-271.6M-32.1M-32.2M-46.7M-55.2M-67M
Capital Expenditures-2.4M-3.9M-3.4M-2.9M-3.6M-1.7M-5.8M-4.6M-10.8M-11.4M-12.6M-12.5M-15.1M-23.6M-27.9M-32.1M-32.2M-46.7M-55.2M-67M
CapEx % of Revenue1.54%2.62%1.47%2.06%1.62%0.87%1.97%1.81%3.6%4.12%4.66%3.7%9.19%7.15%11.63%13.38%10.47%6.46%16.78%16.86%
Acquisitions00000300K00000270.2M00000000
Investments--------------------
Other Investing00020.1M63.1M30M117.8M000-6.3M00-21.8M-243.7M00000
Cash from Financing-11.4M-113.9M-15.9M-6.4M-400K500K-180.3M-50.9M40.7M4.7M-43M-486.9M-10.5M353.1M229.3M-30.7M-70.5M-110M-5M-3.8M
Debt Issued (Net)0-105.6M-6.9M000-194M-51.4M41.1M4.1M-42.9M-496.2M-8.4M351.5M-8.4M-8.4M-8.5M-8.4M-5.6M-5.7M
Equity Issued (Net)-8.6M-7.9M-8.7M-6.2M100K800K9.3M700K-400K200K-100K9.5M0-200K-300K-24.4M-57.5M-102.6M12.5M-30M
Dividends Paid00000000000000000000
Share Repurchases-9M-9.1M-8.9M-6.9M0000-400K0-100K00-200K-300K-24.4M-57.5M-106.3M00
Other Financing-2.8M-400K-300K-200K-500K-300K4.4M-200K-400K400K-100K-200K-2.1M1.8M238M2.1M-4.5M1M-11.9M31.9M
Net Change in Cash-47.6M-40.1M-21.8M118.2M47.2M-50.8M85.4M-8M-32.7M23.9M-800K-341.6M-212.4M401.6M-117.3M-77.7M-140.3M172.3M-43.7M-100.3M
Free Cash Flow-36.2M73.8M-5.7M103.5M-14.8M-81.6M147.9M42.9M-73.4M20.7M47.4M-126.9M-199.1M47.4M-101.9M-47.7M-69.5M282.3M-38.5M-96.7M
FCF Margin %-23.19%49.63%-2.47%73.46%-6.66%-41.91%50.34%16.84%-24.43%7.48%17.52%-37.56%-121.18%14.35%-42.48%-19.88%-22.6%39.03%-11.7%-24.33%
FCF Growth %-144.59%190.44%-103.85%141.26%79.84%-494.2%212.03%133.81%63.13%-56.33%146.52%-166.04%-186.47%-83.21%-164.68%50.67%-36.27%35.01%-164.71%-204.2%
FCF per Share-0.641.41-0.101.91-0.26-1.512.660.82-1.410.400.92-2.50-3.970.95-2.04-0.95-1.375.28-0.72-1.79
FCF Conversion (FCF/Net Income)-4.97x-1.42x-0.04x-8.87x-0.16x2.55x1.34x-0.17x-6.96x-0.65x-0.23x0.44x0.99x-1.39x0.85x0.29x10.08x1.74x-0.51x-6.46x
Interest Paid13.1M8M16.9M8.1M16.7M8.2M19.8M14.5M21.5M11.8M17.7M17.2M21.6M6.3M11.9M3.1M11.7M3.1M11.8M3.1M
Taxes Paid5.3M12.5M10.9M2.1M14.5M-9M9.6M13.5M12.4M14.5M11.4M10.2M16.7M-17.7M3.9M15.2M4.8M14M7.3M48.8M